# US 2003/0069374 A1 · Hexacoordinated ruthenium or osmium metal carbene metathesis catalysts

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0069374 A1
- Document ID: US20030069374A1
- Status: Published application
- Kind: A1
- Application number: 10/172,765
- Filed: 2002-06-14
- Published: 2003-04-10
- Earliest claimed: 2001-08-01
- Assignees: California Institute Technology; Cymetech, LLC
- Inventors: Robert H. Grubbs; Melanie S. Sanford; Jason L. Moore; Jennifer A. Love; Tina M. Trnka
- Web page: https://patentgrep.com/patent/US20030069374A1

## CPC

- C07C 6/04: at a carbon-to-carbon double bond
- B01J 31/181: {Cyclic ligands, including e.g. non-condensed polycyclic ligands, comprising at least one complexing nitrogen atom as ring member, e.g. pyridine}
- B01J 31/1815: {with more than one complexing nitrogen atom, e.g. bipyridyl, 2-aminopyridine}
- B01J 31/182: {comprising aliphatic or saturated rings}
- B01J 31/1825: {Ligands comprising condensed ring systems, e.g. acridine, carbazole}
- B01J 31/183: {with more than one complexing nitrogen atom, e.g. phenanthroline}
- B01J 31/2273: {with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes}
- C07C 6/06: at a cyclic carbon-to-carbon double bond
- C07F 15/002: {Osmium compounds}
- C07F 15/0046: {Ruthenium compounds}
- C08G 61/06: prepared by ring-opening of carbocyclic compounds
- B01J 23/462: {Ruthenium}
- B01J 23/466: {Osmium}
- B01J 31/28: of the platinum group metals, iron group metals or copper
- B01J 2231/14: Other (co) polymerisation, e.g. of lactides or epoxides
- B01J 2231/543: alkene metathesis
- B01J 2531/821: Ruthenium
- B01J 2531/825: Osmium
- C07C 2531/22: Organic complexes
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

The present invention relates to novel hexacoordinated metathesis catalysts and to methods for making and using the same. The inventive catalysts are of the formula 1 wherein: M is ruthenium or osmium; X and X1 are the same or different and are each independently an anionic ligand; L, L1′ and L2 are the same or different and are each independently a neutral electron donor ligand; and, R and R1 are each independently hydrogen or a substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl and silyl. Optionally, each of the R or R1 substituent group may be substituted with one or more moieties selected from the group consisting of C1-C10 alkyl, C1-C10 alkoxy, and aryl which in turn may each be further substituted with one or more groups selected from a halogen, a C1-C5 alkyl, C1-C5 alkoxy, and phenyl. Moreover, any of the catalyst ligands may further include one or more functional groups. Examples of suitable functional groups include but are not limited to: hydroxyl, thiol, thioether, ketone, aldehyde, ester, ether, amine, imine, amide, nitro, carboxylic acid, disulfide, carbonate, isocyanate, carbodiimide, carboalkoxy, carbamate, halogen, alcohol, sulfonic acid, phosphine, imide, acetal, ketal, boronate, cyano, cyanohydrin, hydrazine, enamine, sulfone, sulfide, and sulfenyl. In certain embodiments, at least one of L, L1′ and L2 is an N-heterocyclic carbene ligand.

## Claims

### Claim 1

A compound of the formula:
36
wherein
M is ruthenium or osmium;
X and X1 are the same or different and are each independently any anionic ligand;
L, L1′, and L2 are the same or different and are each independently any neutral electron donor ligand;
R and R1 are the same or different and are each independently hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl, C1-C20 alkylsulfinyl, and silyl.

### Claim 2 (depends on 1)

The compound of claim 1 wherein at least one of the R and R1 substituent group is substituted with one or more moieties selected from the group consisting of C1-C10 alkyl, C1-C10 alkoxy, and aryl, and wherein the moiety is substituted or unsubstituted.

### Claim 3 (depends on 2)

The compound of claim 2 wherein the moiety is substituted with one or more groups selected from the group consisting of halogen, a C1-C5 alkyl, C1-C5 alkoxy, and phenyl.

### Claim 4 (depends on 1)

The compound of claim 1 wherein R is hydrogen and R1 is selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, and aryl.

### Claim 5 (depends on 4)

The compound of claim 4 wherein R1 is phenyl or vinyl.

### Claim 6 (depends on 1)

The compound of claim 1 wherein X and X1 are each independently hydrogen, halide, or selected from the group consisting of C1-C20 alkyl, aryl, C1-C20 alkoxide, aryloxide, C3-C20 alkyldiketonate, aryldiketonate, C1-C20 carboxylate, arylsulfonate, C1-C20 alkylsulfonate, C1-C20 alkylthio, C1-C20 alkylsulfonyl, or C1-C20 alkylsulfinyl, wherein X and X1 is each independently substituted or unsubstituted.

### Claim 7 (depends on 6)

The compound of claim 6 wherein at least one of X and X1 is substituted with one or more moieties selected from the group consisting of C1-C10 alkyl, C1-C10 alkoxy, and aryl, wherein the moiety is substituted or unsubstituted.

### Claim 8 (depends on 7)

The compound of claim 7 wherein the moiety is substituted with one or more groups selected from the group consisting of halogen, C1-C5 alkyl, C1-C5 alkoxy, and phenyl.

### Claim 9 (depends on 1)

The compound of claim 1 wherein X and X1 are each independently selected from the group consisting of halide, benzoate, C1-C5 carboxylate, C1-C5 alkyl, phenoxy, C1-C5 alkoxy, C1-C5 alkylthio, aryl, and C1-C5 alkyl sulfonate.

### Claim 10 (depends on 9)

The compound of claim 9 wherein X and X1 are each independently selected from the group consisting of halide, CF3CO2, CH3CO2, CFH2CO2, (CH3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate.

### Claim 11 (depends on 1)

The compound of claim 1 wherein L, L1′ and L2 are each independently selected from the group consisting of a monodentate, bidentate or tetradentate neutral electron donor ligand.

### Claim 12 (depends on 11)

The compound of claim 11 wherein L, L1′ and L2 are each independently selected from the group consisting of phosphine, sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide, imine, sulfoxide, carboxyl, nitrosyl, pyridine, and thioether, N-heterocyclic carbene ligand or any derivatives therefrom.

### Claim 13 (depends on 1)

The compound of claim 1 wherein both L1′ and L2 are either the same or different N-heterocyclic carbene ligands.

### Claim 14 (depends on 1)

The compound of claim 1 wherein the N-heterocyclic carbene ligand is selected from the group consisting of:
37
wherein R, R1, R6, R7, R8, R9, R10, and R11 are each independently hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl.

### Claim 15 (depends on 1)

The compound of claim 1 wherein L is an N-heterocyclic carbene ligand or a phosphine, and L1′ and L2 are each heterocyclic ligands.

### Claim 16 (depends on 15)

The compound of claim 15 wherein at least one of L1′ and L2 is aromatic

### Claim 17 (depends on 15)

The compound of claim 15 wherein L1′ and L2 together form a bidenatate ligand.

### Claim 18 (depends on 1)

The compound of claim 1 at least one of L1′ and L2 is a unsubstituted or substituted heteroarene selected from the group consisting of furan, thiophene, pyrrole, pyridine, bipyridine, picolylimine, gamma-pyran, gamma-thiopyran, phenanthroline, pyrimidine, bipyrimidine, pyrazine, indole, coumarone, thionaphthene, carbazole, dibenzofuran, dibenzothiophene, pyrazole, imidazole, benzimidazole, oxazole, thiazole, dithiazole, isoxazole, isothiazole, quinoline, bisquinoline, isoquinoline, bisisoquinoline, acridine, chromene, phenazine, phenoxazine, phenothiazine, triazine, thianthrene, purine, bisimidazole and bisoxazole.

### Claim 19 (depends on 18)

The compound of claim 18 wherein at least one of L1′ and L2 is a substituted or unsubstituted pyridine or a substituted or unsubstituted pyridine derivative.

### Claim 20 (depends on 18)

The compound of claim 18 wherein the substituted or unsubstituted heteroarene is selected from the group consisting of:
38

### Claim 21 (depends on 1)

The compound of claim 1 wherein at least one of L1′ and L2 is a unsubstituted or substituted heterocycle selected from the group consisting of:
39
wherein R is selected from the group consisting of C1-C20 alkyl, aryl, ether, amide, halide, nitro, ester, pyridyl.

### Claim 22

A compound of the formula:
40
wherein
M is ruthenium;
X and X1 are each independently selected from the group consisting of halide, CF3CO2, CH3CO2, CFH2CO2, (CH3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate;
L is any neutral electron donor ligand;
L1′ and L2 are the same or different and are each a substituted or unsubstituted heteroarene, and wherein L1′ and L1′ may be joined.
R is hydrogen and R1 is selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, and aryl.

### Claim 23 (depends on 22)

The compound of claim 22 wherein X and X1 are each Cl, L is (IMesH2), L1′ and L2 are each independently a pyridine or pyridine derivative; R is hydrogen and R1 is phenyl or vinyl.

### Claim 24

A compound selected from the group consisting of:
41
wherein sIMES or IMesH2 is
42

### Claim 25

A method for the metathesis of a cyclic or acyclic olefin comprising contacting the olefin with a compound of the formula:
43
wherein
M is ruthenium or osmium;
X and X1 are the same or different and are each independently any anionic ligand;
L, L1′, and L2 are the same or different and are each independently any neutral electron donor ligand;
R and R1 are the same or different and are each independently hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl, C1-C20 alkylsulfinyl, and silyl.

### Claim 26 (depends on 25)

The method of claim 25 wherein M is ruthenium;
X and X1 are each independently selected from the group consisting of halide, CF3CO2, CH3CO2, CFH2CO2, (CH3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate;
L is an N-heterocyclic carbene ligand or a phosphine;
L1′ and L2 are the same or different and are each a substituted or unsubstituted heteroarene;
R is hydrogen and R1 is selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, and aryl.

### Claim 27 (depends on 26)

The method of claim 26 wherein X and X1 are each Cl, L is (IMesH2) or a phosphine, L1′ and L2 are each independently a pyridine or pyridine derivative; R is hydrogen and R1 is phenyl or vinyl.

### Claim 28

A method for the ring-opening metathesis polymerization of a cyclic olefin comprising contacting the olefin with a compound of the formula
44
wherein
X and X1 are each independently selected from the group consisting of halide, CF3CO2, CH3CO2, CFH2CO2, (CH3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate;
L is any neutral electron donor ligand;
L1′ and L2 are the same or different and are each a substituted or unsubstituted heteroarene;
R is hydrogen and R1 is selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, and aryl.

### Claim 29 (depends on 28)

The method of claim 28 wherein the olefin is substituted or unsubstituted norbornene or a norbornene-type monomer or derivative therefrom.

### Claim 30 (depends on 29)

The method of claim 29 wherein the olefin is substituted or unsubstituted dicyclopentadiene.

### Claim 31 (depends on 29)

The method of claim 29 wherein the olefin is a mixture of one or more substituted or unsubstituted norbornenes or norbornene-type monomers or derivatives therefrom.

### Claim 32

A compound of the formula:
45
wherein
M is ruthenium or osmium;
X and X1 are the same or different and are each independently any anionic ligand;
L, L1′, and L2 are the same or different and are each independently any neutral electron donor ligand;
R is hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl;
R1 is substituted or unsubstituted C2-C20 alkenyl.

### Claim 33 (depends on 32)

The compound of claim 32 wherein R1 is substituted or unsubstituted vinyl.

### Claim 34

A method for the synthesis of a ruthenium or osmium hexacoordinated metathesis catalyst comprising contacting a ruthenium or osmium pentacoordinated metal carbene metathesis catalyst with a neutral electron donor ligand.

### Claim 35 (depends on 34)

The method of claim 34 wherein the catalyst is of the formula:
46
wherein
M is ruthenium or osmium;
X and X1 are the same or different and are each independently any anionic ligand;
L, L1′, and L2 are the same or different and are each independently any neutral electron donor ligand;
R and R1 are the same or different and are each independently hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl, and silyl.

### Claim 36 (depends on 35)

The method of claim 35 wherein L, L1′ and L2 are each independently selected from the group consisting of a monodentate, bidentate or tetradentate neutral electron donor ligand.

### Claim 37 (depends on 35)

The method of claim 35 wherein L, L1′ and L2 are each independently selected from the group consisting of phosphine, sulfonated phosphine, phosphite, phosphinite, phosphonite, arsine, stibine, ether, amine, amide, imine, sulfoxide, carboxyl, nitrosyl, pyridine, and thioether, N-heterocyclic carbene ligand or any derivatives therefrom.

### Claim 38 (depends on 37)

The method of claim 37 wherein both L1′ and L2 are either the same or different N-heterocyclic carbene ligands.

### Claim 39 (depends on 38)

The method of claim 38 wherein the N-heterocyclic carbene ligand is selected from the group consisting of:
47
wherein R, R1, R6, R7, R8, R9, R10, and R11 are each independently hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl.

### Claim 40 (depends on 35)

The method of claim 35 wherein L is an N-heterocyclic carbene ligand, and L1′ and L2 are each heterocyclic ligands.

### Claim 41 (depends on 35)

The method of claim 35 at least one of L1′ and L2 is a unsubstituted or substituted heteroarene selected from the group consisting of furan, thiophene, pyrrole, pyridine, bipyridine, picolylimine, gamma-pyran, gamma-thiopyran, phenanthroline, pyrimidine, bipyrimidine, pyrazine, indole, coumarone, thionaphthene, carbazole, dibenzofuran, dibenzothiophene, pyrazole, imidazole, benzimidazole, oxazole, thiazole, dithiazole, isoxazole, isothiazole, quinoline, bisquinoline, isoquinoline, bisisoquinoline, acridine, chromene, phenazine, phenoxazine, phenothiazine, triazine, thianthrene, purine, bisimidazole and bisoxazole, or derivatives therefrom.

### Claim 42 (depends on 41)

The method of claim 41 wherein at least one of L1′ and L2 is a substituted or unsubstituted pyridine or a substituted or unsubstituted pyridine derivative.

### Claim 43

A method for the synthesis of a ruthenium or osmium hexacoordinated metathesis catalyst of the formula:
48
comprising contacting a ruthenium or osmium pentacoordinated metal carbene metathesis catalyst with a neutral electron donor ligand;
wherein
M is ruthenium;
X and X1 are each independently selected from the group consisting of halide, CF3CO2, CH3CO2, CFH2CO2, (CH3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate;
L is any neutral electron donor ligand;
L1′ and L2 are the same or different and are each a substituted or unsubstituted heteroarene; and
R is hydrogen and R1 is selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, and aryl.

### Claim 44

A method for polymerizing an olefin comprising:
contacting a compound of the formula:
49
with a compound of the formula:
50
and a cyclic or acyclic olefin;
wherein
M is ruthenium or osmium;
X and X1 are the same or different and are each independently any anionic ligand;
L, L1′, and L2 are the same or different and are each independently any neutral electron donor ligand;
R, R1, R6, R7, R8, R9, R10 and R11 are the same or different and are each independently hydrogen or a substituted or unsubstituted substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl and silyl; and
A is hydrogen, Si, Sn, Li, Na, MgX3 and acyl, wherein X3 is any halogen and B is selected from the group consisting of CCl3; CH2SO2Ph; C6F5; OR21; and
N(R22)(R23), wherein R21 is selected from the group consisting of Me, C2H5, i-C3H7, CH2CMe3, CMe3, C6H, 1 (cyclohexyl), CH2Ph, CH2norbornyl, CH2norbornenyl, C6H5, 2,4,6-(CH3)3C6H2 (mesityl), 2,6-i-Pr2C6H2, 4-Me—C6H4 (tolyl), 4-C1-C6H4; and wherein R22 and R23 are each independently selected from the group consisting of Me, C2H5, i-C3H7, CH2CMe3, CMe3, C6H11 (cyclohexyl), CH2Ph, CH2norbornyl, CH2norbornenyl, C6H5, 2,4,6-(CH3)3C6H2 (mesityl), 2,6-1-Pr2C6H2, 4-Me—C6H4 (tolyl), 4-C1-C6H4).

### Claim 45 (depends on 44)

The method of claim 44 wherein
M is ruthenium;
X and X1 are each independently selected from the group consisting of halide, CF3CO2, CH3CO2, CFH2CO2, (CH3)3CO, (CF3)2(CH3)CO, (CF3)(CH3)2CO, PhO, MeO, EtO, tosylate, mesylate, or trifluoromethanesulfonate;
L is any neutral electron donor ligand;
L1′ and L2 are the same or different and are each a substituted or unsubstituted heteroarene;
R is hydrogen and R1, R6, R7, R8, R9, R10, R11 are each independently selected from the group consisting of hydrogen, C1-C20 alkyl, C2-C20 alkenyl, and aryl;
A is hydrogen and B is CCl3.

### Claim 46 (depends on 44)

The method of claim 44 wherein the olefin is a substituted or unsubstituted norbornene or a norbornene-type monomer or derivative therefrom.

### Claim 47 (depends on 44)

The method of claim 44 wherein the olefin is substituted or unsubstituted dicyclopentadiene.

### Claim 48 (depends on 44)

The method of claim 44 wherein the olefin is a mixture of one or more substituted or unsubstituted norbornenes or norbornene-type monomers or derivatives therefrom.

### Claim 49 (depends on 1)

The compound of claim 1 wherein at least one of L, L1′ and L2 is an N-heterocyclic carbene ligand.
